Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
GRP78/BiP has recently emerged as a novel biomarker for aggressive prostate cancer. Here, we report that homozygous deletion of Grp78 specifically in mouse prostate epithelium suppresses prostate tumorigenesis without affecting postnatal prostate development and growth. Mouse prostates with double conditional knockout of Grp78 and Pten exhibit normal histology and cytology, in contrast to the invasive adenocarcinoma in mouse prostates with Pten inactivation. AKT activation in Pten null prostate epithelium is inhibited by Grp78 homozygous deletion, corresponding with suppression of AKT phosphorylation by GRP78 knockdown in prostate cancer cell line. Thus, inactivation of GRP78 may represent a previously undescribed approach to stop prostate cancer and potentially other cancers resulting from the loss of PTEN tumor suppression and/or activation of the oncogenic AKT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, suppression of BiP signaling by KP1339 (also known as IT‐139) or HA15 in glioblastoma, bladder or breast cancer cell lines has been shown to enhance the response to anti‐cancer therapy [194, 195].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 1×
“Pten homozygous deletion in mice causes early embryonic death, and Pten / mice exhibit hyperplastic-dysplastic changes in multiple organs, including PIN in mouse prostate but no progression to adenocarcinoma (13).”
BackgroundWang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · cited 7×
“transgene and f Pten allele on C57BL/6xDBA2/129 background was described previously (15).”
BackgroundResultSelf-citationTenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034 · cited 1×
“If so, what is the underlying mechanism? One of the most common genes involved in prostate cancer is Pten, a nonredundant phosphatase gene frequently deleted or mutated in human cancers (11).”
BackgroundThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921 · cited 1×
“As a result, phosphorylation of a wide range of downstream signaling molecules leads to enhanced cell growth and survival (12).”
BackgroundGRP78 Induction in Cancer: Therapeutic and Prognostic Implications
Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0325 · Cited by 856 · cited 3×
“GRP78 is highly induced in a wide range of tumors through intrinsic factors such as altered glucose metabolism of cancer cells, compounded by extrinsic factors such as glucose deprivation, hypoxia, and acidosis in the microenvironment of poorly-perfused solid tumor (7).”
BackgroundER chaperones in mammalian development and human diseases
Ni, M., & Lee, A. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.045 · Cited by 735 · cited 1×
“As a major endoplasmic reticulum (ER) chaperone, GRP78 facilitates protein folding and assembly, protein quality control, ER-associated protein degradation, Ca2 binding, and regulation of transmembrane ER stress inducers (4, 5).”
BackgroundAging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation
Chambers, S. M., Shaw, C. A., Gatza, C., Fisk, C. J., Donehower, L. A., & Goodell, M. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050201 · Cited by 731 · cited 1×
“It is also tempting to speculate that GRP78 may have a role in cancer stem cells, because it is required for survival of embryonic stem cell precursors and is among a set of select genes expressed in hematopoietic stem cells (6, 30).”
BackgroundReddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695 · cited 1×
“In addition to maintenance of ER homeostasis through protein quality control and serving as an ER Ca2 binding protein, GRP78 with antiapoptotic properties is known to protect cancer cells against immune surveillance (25), and directly interacts with and inhibits caspase-7 (26).”
BackgroundSelf-citationStress Induction of GRP78/BiP and Its Role in Cancer
Li, J., & Lee, A. (2006) · Current Molecular Medicine · doi:10.2174/156652406775574523 · Cited by 599
The ER function BiP is a master regulator of ER function.
Hendershot, L. M. (2004) · PubMed · Cited by 542
Li, J., Ni, M., Lee, B., Barron, E., Hinton, D. R., & Lee, A. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.81 · Cited by 452 · cited 1×
“Most recently, GRP78 is determined to be obligatory for stress-induced autophagy, which has been implicated in cancer progression (29).”
BackgroundPyrko, P., Schönthal, A. H., Hofman, F. M., Chen, T. C., & Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0625 · Cited by 450
Luo, S., Mao, C., Lee, B., & Lee, A. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00779-06 · Cited by 430 · cited 5×
“It is expressed as early as at the 2-cell stage of embryonic development, and is essential for proliferation and survival of embryonic cells (6).”
BackgroundMethodArap, M. A., Lahdenranta, J., Mintz, P. J., Hajitou, A., Sarkis, Á. S., Arap, W., & Pasqualini, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.018 · Cited by 412 · cited 1×
“Also, GRP78 can exist as a cell surface protein in some cell types, including prostate cancer cells and transmit extracellular stimuli to intracellular AKT signaling pathways to promote both growth and survival (20, 21, 24).”
BackgroundWu, X., Wu, J., Huang, J., Powell, W. C., Zhang, J., Matusik, R. J., Sangiorgi, F. O., Maxson, R. E., Sucov, H. M., & Roy-Burman, P. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00551-7 · Cited by 390 · cited 1×
“The expression of Cre recombinase is driven by PB-Cre4 promoter construct (16), which is an engineered derivative of rat probasin promoter.”
BackgroundDong, D., Ni, M., Li, J., Xiong, S., Ye, W., Virrey, J. J., Mao, C., Ye, R., Wang, M., Pen, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2950 · Cited by 375 · cited 1×
“In a transgenic mouse model of mammary tumor, Grp78 heterozygosity does not affect organ development and growth, but prolongs the tumor latency period, increases apoptosis, suppresses tumor proliferation, and specifically blocks tumor angiogenesis (31).”
BackgroundFingerprinting the circulating repertoire of antibodies from cancer patients
Mintz, P. J., Kim, J., Do, K.-A., Wang, X., Zinner, R. G., Cristofanilli, M., Arap, M. A., Hong, W. K., Troncoso, P., Logothetis, C. J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt774 · Cited by 345 · cited 1×
“The 78-kDa glucose regulated protein (GRP78) was initially linked to prostate cancer progression and metastasis through epitope mapping of humoral immune response from cancer patients, and identified as a functional molecular target for circulating ligands (1).”
BackgroundHu, P., Han, Z., Couvillon, A. D., & Exton, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407700200 · Cited by 321 · cited 1×
“Similar observations have been reported for glial and breast cancer cells (18, 19).”
ResultFu, Y., Li, J., & Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4594 · Cited by 304 · cited 1×
“Also, GRP78 could block initiation of apoptosis by inhibiting the proapoptotic BH3 protein BIK, which is a downstream effector of p53 and its loss is implicated in the development of human breast and colorectal cancers (9, 27).”
BackgroundMisra, U. K., Deedwania, R., & Pizzo, S. V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511694200 · Cited by 262
Daneshmand, S., Quek, M. L., Lin, E., Lee, C., Cote, R. J., Hawes, D., Cai, J., Groshen, S., Lieskovsky, G., Skinner, D. G., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.03.014 · Cited by 212 · cited 1×
“Recent studies further revealed that 2/3 of human prostate cancers expressed high level of GRP78, associating with recurrence, development of castration-resistance, and poor survival (2, 3).”
BackgroundGenetically defined mouse models that mimic natural aspects of human prostate cancer development.
Roy-Burman, P., Wu, H., Powell, W. C., Hagenkord, J., & Cohen, M. B. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110225 · Cited by 165 · cited 1×
“There was only mild to moderate hyperplasia in occasional areas, with normal cytological features and intact basement membrane, which was also observed in age-matched wild type mice as reported previously (17).”
ResultPootrakul, L., Datar, R. H., Shi, S.-R., Cai, J., Hawes, D., Groshen, S. G., Lee, A. S., & Cote, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0133 · Cited by 141 · cited 1×
“Recent studies further revealed that 2/3 of human prostate cancers expressed high level of GRP78, associating with recurrence, development of castration-resistance, and poor survival (2, 3).”
BackgroundPhilippova, M., Ivanov, D., Joshi, M. B., Kyriakakis, E., Rupp, K., Afonyushkin, T., Bochkov, V., Erne, P., & Resink, T. J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00157-08 · Cited by 130 · cited 2×
“Supporting the result of the mouse model study, knockdown of GRP78 by siRNA in human prostate cancer cells inhibited AKT phosphorylation, which is consistent with previous reports that GRP78 down-regulation inhibited AKT activation in 1-LN prostate cancer cells with intact PTEN (20) and in human endothelial cells (21).”
BackgroundResultAkt up- and down-regulation in response to endoplasmic reticulum stress
Hosoi, T., Hyoda, K., Okuma, Y., Nomura, Y., & Ozawa, K. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.052 · Cited by 97 · cited 1×
“Similar observations have been reported for glial and breast cancer cells (18, 19).”
ResultA region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
Castells, A., Gusella, J. F., Ramesh, V., & Rustgi, A. K. (2000) · PubMed · Cited by 88
Sugawara, S., Takeda, K., Lee, A. S., & Dennert, G. (1993) · PubMed · Cited by 87
Liao, C., Zhong, C., Saribekyan, G., Bading, J. R., Park, R., Conti, P. S., Moats, R. A., Berns, A. J. M., Shi, W., Zhou, Z., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0668 · Cited by 80 · cited 2×
“PB-Cre4 expression is postnatal, androgen regulated, and highly specific for prostate epithelial secretory cells, with robust activity to act on at least up to 4 alleles in a single cell (14).”
BackgroundConditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium
Sutherland, B. W., Knoblaugh, S. E., Kaplan-Lefko, P. J., Wang, F., Holzenberger, M., & Greenberg, N. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6531 · Cited by 66 · cited 1×
“In contrast to our observations, knockout of systemic IGF1 or prostatic IGF1R, both of which are an upstream factor of AKT, does not affect carcinogenesis in the prostate (22, 23).”
ResultAnzo, M., Cobb, L. J., Hwang, D., Mehta, H. H., SAID, J. W., Yakar, S., LeRoith, D., & Cohen, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3165 · Cited by 54 · cited 1×
“In contrast to our observations, knockout of systemic IGF1 or prostatic IGF1R, both of which are an upstream factor of AKT, does not affect carcinogenesis in the prostate (22, 23).”
Yang, G., Sun, Q., Teng, Y., Li, F., Weng, T., & Yang, X. Y. (2008) · Development · doi:10.1242/dev.028118 · Cited by 52
Research works printed but not linked: 1
- Fu et al. PNAS ͉ December 9, 2008 ͉ vol. 105 ͉ no. 49 ͉ 19449 MEDICAL SCIENCES
Cited by
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Cao, S. S., & Kaufman, R. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5851 · Cited by 1,363
“In addition, conditional knockout of Bip in the prostate of mice with Pten inactivation suppressed prostate cancer growth (54).”
BackgroundEndoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356
GRP78: A cell's response to stress
Ibrahim, I. M., Abdelmalek, D. H., & Elfiky, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.022 · Cited by 647
“These results are in agreement with other types of cancers such as colon cancer [92], and prostate cancer [93].”
Wang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2485 · Cited by 609
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Lee, A. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3701 · Cited by 587
Metadata
- Authors
- Fu, Y., Wey, S., Wang, M., Ye, R., Liao, C.-P., Roy-Burman, P., & Lee, A. S.
- Affiliations
- University of Southern California (US)
- Departments of aBiochemistry and Molecular Biology and
- Pathology, University of Southern California Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-12-09
- Volume
- 105
- Issue
- 49
- Pages
- 19444-19449
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2614780
- OpenAlex
- W2008683065
- Cited by
- 180
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 10 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 20 · 2013: 14 · 2012: 16
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Southern California
- University of California, Los Angeles
- National Cancer Institute (CA 113392, R01CA027607, CA27607, R01CA113392)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- GRP78, PTEN, prostate cancer, prostate tumorigenesis, Akt activation, Akt phosphorylation, conditional knockout, prostate epithelium, ER chaperones, tumor suppressor loss, invasive adenocarcinoma, mouse model
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Adenocarcinoma, Animals, Epithelium, Fluorescent Antibody Technique, Heat-Shock Proteins, Homozygote, Male, Mice, Inbred C57BL, Prostate, Prostatic Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice, Knockout, Molecular Chaperones, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.